PANCREATIC CANCER, ADVANCED OR METASTATIC
Clinical trials for PANCREATIC CANCER, ADVANCED OR METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER, ADVANCED OR METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER, ADVANCED OR METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for pancreatic cancer: targeted combo trial for BRCA/PALB2 patients
Disease control Recruiting nowThis study tests a new combination of chemotherapy drugs (NABPLAGEM) against the standard combo for people with advanced pancreatic cancer that has a BRCA1/2 or PALB2 gene mutation. The goal is to see if the new combo works better at shrinking tumors and helping people live longe…
Matched conditions: PANCREATIC CANCER, ADVANCED OR METASTATIC
Phase: PHASE2, PHASE3 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New cancer pill shows promise in early trial
Disease control Recruiting nowThis study tests an experimental drug called CP-383 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if CP-383 can slow or stop cancer growth and to find the safest and most effective dose. About 150 participants will take th…
Matched conditions: PANCREATIC CANCER, ADVANCED OR METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Tasca Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:53 UTC